Memento Medicines

Chester, United Kingdom

Memento Medicines is a biotech developing bispecific antibody therapies for eye diseases.

$93.0M raised

Jun 2026

Series A

Biotechnology Medical

Top Investors

RA Capital Management Samsara BioCapital Forbion Capital Partners Sanofi Ventures Avego Bioscience Capital

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Memento Medicines

How much funding has Memento Medicines raised?

Memento Medicines has raised $93.0M in total funding. The most recent round was Series A. The last funding was announced in June 2026.

Who are Memento Medicines's investors?

Memento Medicines's investors include RA Capital Management, Samsara BioCapital, Forbion Capital Partners, Sanofi Ventures, Avego Bioscience Capital.

Where is Memento Medicines headquartered?

Memento Medicines is headquartered in Chester, United Kingdom.

What does Memento Medicines do?

Memento Medicines is a biotech developing bispecific antibody therapies for eye diseases.

What stage is Memento Medicines at?

Memento Medicines is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 18, 2026.

MLA

"Memento Medicines — Funding & Investors." VCBacked, June 18, 2026, https://www.vcbacked.co/company/memento-medicines. Accessed July 7, 2026.

APA

VCBacked. (2026). Memento Medicines — Funding & Investors. Retrieved July 7, 2026, from https://www.vcbacked.co/company/memento-medicines

Wikipedia (cite web)

{{cite web |title=Memento Medicines — Funding & Investors |url=https://www.vcbacked.co/company/memento-medicines |website=VCBacked |access-date=July 7, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 18, 2026.

Similar Companies in Biotechnology

View all

Allterum Therapeutics

Houston$1.0M

Renaissance BioScience

Advanced Microbiome Interventions

Amsterdam$300K